Semaglutide Assessment
Use when asked to administer, score, or explain a Semaglutide Assessment — GLP-1 receptor agonist eligibility screening — grounded in FormExamples/form-examples.
GLP-1 receptor agonist eligibility screening for semaglutide therapy, evaluating absolute/relative contraindications, metabolic profile, and treatment planning.
Scoring
Instrument: Eligibility Status — Eligible / Conditional / Ineligible.
What it covers
Demographics; indication and goals; body composition; metabolic profile; cardiovascular risk; contraindications screening; GI history; current medications; mental health screening; and treatment plan.
Common pitfalls
- Skipping GI history — GLP-1 receptor agonists commonly cause GI side effects and are contraindicated or used cautiously in certain GI conditions (e.g. a history of pancreatitis, gastroparesis); omitting this section misses clinically important context.
- Treating "Conditional" eligibility as a green light without addressing the condition — the category implies a specific modification or monitoring requirement, not automatic approval to proceed unchanged.
- Assessing eligibility without also screening mental health — GLP-1 therapy for weight management intersects with body image and eating behavior; the mental health screening section exists to catch relevant concerns before starting treatment.
Learn more
- FormExamples: semaglutide-assessment for the full implementation, clinical references, and worked examples.
- Diabetes Assessment for a related metabolic assessment.